Please login to the form below

Not currently logged in
Email:
Password:

Chiltern appoints Roger Hunter to partnerships role

He will be tasked with developing long-term strategic partnerships

Chiltern Roger HunterUK-headquartered contract research organisation (CRO) has appointed Roger Hunter as vice president of strategic partnerships within its business development team.

He brings 25 years of pharma and biotech experience to the company and his most recent industry-side role was as VP of operations for a speciality pharmaceutical company.

Chiltern's VP of global business development Stuart McGuire said: “It gives me great pleasure to welcome Roger Hunter as Chiltern's new VP of strategic partnerships. Roger comes to us with a strong background in both commercial and development functions within pharma and biotech. He has a strong understanding of clinical development and a deep appreciation of the impact that we have on our clients.”

Roger Hunter added: “I look forward to working in close collaboration with our sponsors to develop long standing strategic partnerships with them through the delivery of innovative, quality and flexible solutions that address their key needs.” 

16th January 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...